Curaleaf Holdings (CURLF) Non Operating Income (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Non Operating Income of -$29.4 million in Q1 2026, up 99.89% quarter-over-quarter from -$27.0 billion in Q4 2025, and down 14.03% on a YoY basis from -$34.2 million in Q1 2025.
Curaleaf Holdings (CURLF) Non Operating Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Non Operating Income history runs 8 years deep, the most recent figure standing at -$29.4 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 14.03% year-over-year to -$29.4 million; the TTM figure through Mar 2026 stood at -$49.6 billion (down 43750.47% YoY), while the FY2025 annual figure was -$103.7 million, up 24.94% from the prior year.
- Non Operating Income was -$29.4 million for Q1 2026 at Curaleaf Holdings, up from -$27.0 billion in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $7.4 million in Q2 2023 to a low of -$74.6 billion in Q4 2023.
- Historically, Non Operating Income has averaged -$7.3 billion across 5 years, with a median of -$21.1 million in 2023.
- Biggest YoY gain for Non Operating Income was 330.2% in 2023; the steepest drop was 2793845.32% in 2023.
- A 5-year view of Non Operating Income shows it stood at $2.7 million in 2022, then slumped by 2793845.32% to -$74.6 billion in 2023, then jumped by 99.91% to -$68.2 million in 2024, then sank by 39537.96% to -$27.0 billion in 2025, then soared by 99.89% to -$29.4 million in 2026.
- The last three Non Operating Income figures came in at -$29.4 million (Q1 2026), -$27.0 billion (Q4 2025), and -$28.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -29.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.38 Mn |
| Dec 31, 2025 | -27.04 Bn |
| Sep 30, 2025 | -28.34 Mn |
| Jun 30, 2025 | -22.51 Bn |
| Mar 31, 2025 | -25.77 Mn |
| Dec 31, 2024 | -68.23 Mn |
| Sep 30, 2024 | -21.01 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -74.59 Bn |
| Sep 30, 2023 | -2.80 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Mar 31, 2023 | -21.13 Mn |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | -3.20 Mn |
| Mar 31, 2022 | -22.35 Mn |
| Dec 31, 2021 | -22.31 Mn |
| Sep 30, 2021 | -13.90 Mn |
| Jun 30, 2021 | -19.03 Mn |